MedTrace Logo

Exoskeleton Training for Spinal Cord Injury Neuropathic Pain (ExSCIP)

NCT06463418 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-05-01

No results posted yet for this study

Summary

The goal of this feasibility trial is to learn if exoskeleton or robotic walking works to reduce nerve (neuropathic) pain after spinal cord injury.

This study asks is:

* Providing walking practice through use of a robotic device (exoskeleton) three times per week for twelve weeks possible to deliver?
* Would people sign up and stick to the programme?
* And will it help to reduce neuropathic pain levels after spinal injury?

Researchers will compare robotic walking and a relaxation program to see if robotic walking works to reduce neuropathic pain levels after spinal injury.

Participants will:

* Complete a number of questionnaires and tests related to their pain before the trial.
* Complete robotic walking or a relaxation program three times per week for twelve weeks.
* Complete the same questionnaires and tests after the trial finishes and 6 months after.
* Complete an interview telling researchers about their experiences of the trial.

Conditions

  • Traumatic Spinal Cord Injury

Interventions

DEVICE

Ekoskeleton (Intervention)

Exoskeleton walking three times per week for 12 weeks.

OTHER

Relaxation (Comparator)

Relaxation three times per week for 12 weeks.

Sponsors & Collaborators

  • Royal College of Surgeons, Ireland

    collaborator OTHER

  • University of Aarhus

    collaborator OTHER

  • University College Dublin

    lead OTHER

Principal Investigators

  • Olive Lennon, PhD · University College Dublin

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-20
Primary Completion
2026-06-30
Completion
2026-11-30

Countries

  • Ireland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06463418 on ClinicalTrials.gov